BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32963614)

  • 1. Potential biomarkers Ang II/AT1R and S1P/S1PR1 predict the prognosis of hepatocellular carcinoma.
    Ji Y; Chen H; Gow W; Ma L; Jin Y; Hui B; Yang Z; Wang Z
    Oncol Lett; 2020 Nov; 20(5):208. PubMed ID: 32963614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II facilitates neointimal formation by increasing vascular smooth muscle cell migration: Involvement of APE/Ref-1-mediated overexpression of sphingosine-1-phosphate receptor 1.
    Lee DY; Won KJ; Lee KP; Jung SH; Baek S; Chung HW; Choi WS; Lee HM; Lee BH; Jeon BH; Kim B
    Toxicol Appl Pharmacol; 2018 May; 347():45-53. PubMed ID: 29609002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S1PR1 induces metabolic reprogramming of ceramide in vascular endothelial cells, affecting hepatocellular carcinoma angiogenesis and progression.
    Wang X; Qiu Z; Dong W; Yang Z; Wang J; Xu H; Sun T; Huang Z; Jin J
    Cell Death Dis; 2022 Sep; 13(9):768. PubMed ID: 36068200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of PLC-β1/CaM signaling pathway mediated by AT1R on the occurrence and development of hepatocellular carcinoma.
    Xu ZW; Liu NN; Wang XY; Ding BC; Zhang HF; Li Y; Sun WY; Wei W
    Cancer Cell Int; 2021 Nov; 21(1):587. PubMed ID: 34727945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AT1R-Specific Ligand Angiotensin II as a Novel SPECT Agent for Hepatocellular Carcinoma Diagnosis.
    Tu Y; Liu Z; Wang F; Liu P; Tao J; Li C; Han Z; Li Z; Ma Y; Gu Y
    ACS Sens; 2020 Dec; 5(12):4072-4080. PubMed ID: 33232127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II and tumor necrosis factor-α stimulate the growth, migration and invasion of BEL-7402 cells via down-regulation of GRK2 expression.
    Xu ZW; Yan SX; Wu HX; Zhang Y; Wei W
    Dig Liver Dis; 2019 Feb; 51(2):263-274. PubMed ID: 30712649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of TNF-α and Ang II on the proliferation, migration and invasion of HepG2 cells by regulating the expression of GRK2.
    Xu ZW; Yan SX; Wu HX; Chen JY; Zhang Y; Li Y; Wei W
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):747-758. PubMed ID: 28315953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of renin-angiotensin system genes with the progression of hepatocellular carcinoma.
    Ye G; Qin Y; Lu X; Xu X; Xu S; Wu C; Wang X; Wang S; Pan D
    Biochem Biophys Res Commun; 2015 Mar; 459(1):18-23. PubMed ID: 25701390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence.
    Uranbileg B; Ikeda H; Kurano M; Enooku K; Sato M; Saigusa D; Aoki J; Ishizawa T; Hasegawa K; Kokudo N; Yatomi Y
    PLoS One; 2016; 11(2):e0149462. PubMed ID: 26886371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Expression of Sphingosine-1-phosphate and Sphingosine-1-phosphate Receptor 1 in Mouse Model of Pulmonary Ischemia-Reperfusion Injury].
    Zhu Q; Zhou WQ; Wan L; Jin ZY; Zhang XH; Lin LN
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Nov; 49(6):891-894. PubMed ID: 32677399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine kinase 1/sphingosine-1-phosphate (S1P)/S1P receptor axis is involved in ovarian cancer angiogenesis.
    Dai L; Liu Y; Xie L; Wu X; Qiu L; Di W
    Oncotarget; 2017 Sep; 8(43):74947-74961. PubMed ID: 29088837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of S1P receptor subtypes in human bladder transitional cell carcinoma.
    Palangi A; Shakhssalim N; Parvin M; Bayat S; Allameh A
    Clin Transl Oncol; 2019 Sep; 21(9):1240-1249. PubMed ID: 30712233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphk1/S1P/S1PR1 Signaling is Involved in the Development of Autoimmune Thyroiditis in Patients and NOD.H-2
    Han C; He X; Xia X; Guo J; Liu A; Liu X; Wang X; Li C; Peng S; Zhao W; Zhou M; Shi X; Li Y; Li Y; Shan Z; Teng W
    Thyroid; 2019 May; 29(5):700-713. PubMed ID: 30963819
    [No Abstract]   [Full Text] [Related]  

  • 14. Essential roles of sphingosine 1-phosphate receptor types 1 and 3 in human hepatic stellate cells motility and activation.
    Liu X; Yue S; Li C; Yang L; You H; Li L
    J Cell Physiol; 2011 Sep; 226(9):2370-7. PubMed ID: 21660960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S1PR1 (Sphingosine-1-Phosphate Receptor 1) Signaling Regulates Blood Flow and Pressure.
    Cantalupo A; Gargiulo A; Dautaj E; Liu C; Zhang Y; Hla T; Di Lorenzo A
    Hypertension; 2017 Aug; 70(2):426-434. PubMed ID: 28607130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
    Yang S; Yang C; Yu F; Ding W; Hu Y; Cheng F; Zhang F; Guan B; Wang X; Lu L; Rao J
    Cell Death Dis; 2018 Oct; 9(11):1105. PubMed ID: 30377291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum sphingosine 1-phosphate in hepatocellular carcinoma patients is related to HBV infection.
    Dong H; Xiao J; Zhu R; Liu B; Dong M; Luo D; Sun T; Li Q; Jin J
    J BUON; 2018; 23(6):1711-1716. PubMed ID: 30610798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA LISPR1 is required for S1P signaling and endothelial cell function.
    Josipovic I; Pflüger B; Fork C; Vasconez AE; Oo JA; Hitzel J; Seredinski S; Gamen E; Heringdorf DMZ; Chen W; Looso M; Pullamsetti SS; Brandes RP; Leisegang MS
    J Mol Cell Cardiol; 2018 Mar; 116():57-68. PubMed ID: 29408197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Axis in Hepatocellular Carcinoma.
    Maceyka M; Rohrbach T; Milstien S; Spiegel S
    Handb Exp Pharmacol; 2020; 259():3-17. PubMed ID: 31321542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine-1-phosphate receptor 1 as a prognostic biomarker and therapeutic target for patients with primary testicular diffuse large B-cell lymphoma.
    Koresawa R; Yamazaki K; Oka D; Fujiwara H; Nishimura H; Akiyama T; Hamasaki S; Wada H; Sugihara T; Sadahira Y
    Br J Haematol; 2016 Jul; 174(2):264-74. PubMed ID: 27061580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.